![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Adis International
ISSN: 1173-5503
Source: PharmacoEconomics and Outcomes News, Vol.1, Iss.279, 2000-01, pp. : 9-9
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Febrile neutropenia costly in the US
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 661, 2012-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 540, 2007-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
US costs highest for AMI hospitalisation
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 495, 2006-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
By Tsatsaris V.
Drugs, Vol. 64, Iss. 4, 2004-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Preterm labour: a pharmacological challenge
By Bernal A.L. Europe-Finner G.N. Phaneuf S. Watson S.P.
Trends in Pharmacological Sciences, Vol. 16, Iss. 4, 1995-04 ,pp. :